Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
Clinical trial NCT05272150 · COMPLETED
Trial details
- NCT number
- NCT05272150
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-13
- Primary completion
- 2025-05-30
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.